01Biohaven Ltd. will report Q3 2026 earnings on November 05, 2026 after market close with expected EPS of -$0.03 versus -$0.00 in the prior year quarter.
02Revenue is projected at $110.0M, representing growth compared to the year-ago quarter.
03The stock trades at $15.24 with a market capitalization of $1.2B.
04Recent earnings history shows significant volatility, with Q3 actual EPS of -$0.73 missing estimates by 2333.3%.
05Investors should evaluate revenue growth, margin trends, and forward guidance rather than focusing solely on earnings per share.
Earnings Results
Biohaven Ltd. (NYSE:BHVN) is scheduled to report its Q3 earnings results on November 05, 2026 after market close.
Analysts expect the Healthcare company to report earnings per share of $-0.03, below the $0.00 reported in the same quarter last year. Revenue is expected to come in at $110.0M, up from a year ago.
Company Overview
The stock currently trades at $15.24 with a market capitalization of $1.2B.
Ahead of Biohaven Ltd.'s earnings report, investors are watching several key metrics beyond the headline EPS number. Revenue growth, margin trends, and forward guidance will likely carry more weight than a single quarter's earnings figure in determining the stock's direction after the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Biohaven Ltd. should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.